MTRI
Mentari Therapeutics, Inc. (MTRI)
Healthcare • NASDAQ • $19.87+6.83%
Key Fundamentals
- Symbol
- MTRI
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Price
- $19.87
- Daily Change
- +6.83%
- Market Cap
- $1.08B
- Trailing P/E
- N/A
- Forward P/E
- N/A
- 52W High
- $23.30
- 52W Low
- $5.75
- Analyst Target
- N/A
- Dividend Yield
- 0.00%
- Beta
- N/A
About Mentari Therapeutics, Inc.
Mentari Therapeutics, Inc., a biotechnology company, develops and provides therapies for migraine prevention. The company's products include MT-001, an anti-PACAP monoclonal antibody designed for convenient subcutaneous dosing; MT-002, an anti-CGRP; and anti-PACAP bispecific antibody designed to inhibit these complementary pathways. The company was incorporated in 2025 and is based in Sacramento, California.
Company websiteResearch MTRI on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.